title: [Report from a small registry-permetrexed, tarceva and yondelis].
authors.affiliation: Klinika Komplexní Oncologické pece, Masarykův Onkologický ústav, Brno. pocjop@mou.cz
authors.forename: L
authors.initials: L
authors.lastname: Pochop
authors.forename: K
authors.initials: K
authors.lastname: Hejduk
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000069347:Erlotinib Hydrochloride; D005971:Glutamates / Q000627:therapeutic use*; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008654:Mesothelioma / Q000188:drug therapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D000068437:Pemetrexed; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D012042:Registries; D012509:Sarcoma / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D005971:Glutamates; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000068437:Pemetrexed; D006147:Guanine; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors